Pre‐clinical diabetic cardiomyopathy: prevalence, screening, and outcome
- 1 September 2010
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 12 (9), 951-957
- https://doi.org/10.1093/eurjhf/hfq110
Abstract
Diabetic cardiomyopathy, characterized by left ventricular (LV) dysfunction and LV hypertrophy independent of myocardial ischaemia and hypertension, could contribute to the increased life-time risk of congestive heart failure seen in patients with diabetes. We assessed prospectively the prevalence, effectiveness of screening methods [brain natriuretic peptide (BNP) and C-reactive protein in combination with clinical parameters], and outcome of pre-clinical diabetic cardiomyopathy. We studied 100 adults (mean age 57.4 +/- 10.2 years, 44% females) with diabetes and no previous evidence of structural heart disease. By echocardiography, diabetic cardiomyopathy was present in 48% of patients. Screening with combinations of clinical parameters (gender, systolic blood pressure, and body mass index), but not BNP, resulted in high negative predictive values for diabetic cardiomyopathy. During a mean follow-up of 48.5 +/- 9.0 months, in the groups with and without diabetic cardiomyopathy, 12.5 vs. 3.9% (P < 0.2) patients died or experienced cardiovascular events and 37.5 vs. 9.6% (P < 0.002) had a deterioration in NYHA functional class. Overall event-free survival was 54 vs. 87% (P = 0.001) in the groups with and without diabetic cardiomyopathy, respectively. Brain natriuretic peptide was an independent predictor of events [odds ratio 3.5 (1.1-10.9), P = 0.02]. Pre-clinical diabetic cardiomyopathy is common. Screening with combinations of simple clinical parameters, but not BNP, can be useful to identify those patients needing further evaluation. Patients with pre-clinical diabetic cardiomyopathy are at increased risk for functional deterioration and possibly cardiovascular events during follow-up. Brain natriuretic peptide was shown to be an independent predictor of future events.This publication has 33 references indexed in Scilit:
- Effect of diabetes and hypertension on left ventricular diastolic function in a high‐risk population without evidence of heart diseaseEuropean Journal of Heart Failure, 2010
- Diabetic Cardiomyopathy RevisitedCirculation, 2007
- Screening for heart disease in diabetic subjectsAmerican Heart Journal, 2005
- Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitusThe American Journal of Cardiology, 2004
- Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health StudyAmerican Heart Journal, 1997
- Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)The American Journal of Cardiology, 1991
- Left ventricular filling determined by Doppler echocardiography in diabetes mellitusThe American Journal of Cardiology, 1988
- The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertensionJournal of the American College of Cardiology, 1986
- Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects.Circulation, 1979
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977